ESCMID guideline for the diagnosis and management of Candida diseases 2012

Diagnostic procedures

M. Cuenca-Estrella, P. E. Verweij, M. C. Arendrup, S. Arikan-Akdagli, J. Bille, J. P. Donnelly, H. E. Jensen, C. Lass-Flörl, M. D. Richardson, M. Akova, M. Bassetti, T. Calandra, E. Castagnola, O. A. Cornely, J. Garbino, A. H. Groll, R. Herbrecht, W. W. Hope, B. J. Kullberg, O. Lortholary & 5 others W. Meersseman, G. Petrikkos, E. Roilides, C. Viscoli, A. J. Ullmann

Research output: Contribution to journalArticle

180 Citations (Scopus)

Abstract

As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and to select the most appropriate antifungal drug. A panel of experts of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) undertook a data review and compiled guidelines for the clinical utility and accuracy of different diagnostic tests and procedures for detection of Candida infections. Recommendations about the microbiological investigation and detection of candidaemia, invasive candidiasis, chronic disseminated candidiasis, and oropharyngeal, oesophageal, and vaginal candidiasis were included. In addition, remarks about antifungal susceptibility testing and therapeutic drug monitoring were made.

Original languageEnglish
Pages (from-to)9-18
Number of pages10
JournalClinical Microbiology and Infection
Volume18
Issue numberSUPPL.7
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Candidiasis
Disease Management
Microbiology
Candida
Communicable Diseases
Invasive Candidiasis
Guidelines
Candidemia
Mycoses
Drug Monitoring
Infection
Routine Diagnostic Tests
Mortality
Pharmaceutical Preparations
Therapeutics

Keywords

  • Biomarkers
  • Candida
  • Diagnosis
  • Guideline
  • Noncultural

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Medicine(all)

Cite this

Cuenca-Estrella, M., Verweij, P. E., Arendrup, M. C., Arikan-Akdagli, S., Bille, J., Donnelly, J. P., ... Ullmann, A. J. (2012). ESCMID guideline for the diagnosis and management of Candida diseases 2012: Diagnostic procedures. Clinical Microbiology and Infection, 18(SUPPL.7), 9-18. https://doi.org/10.1111/1469-0691.12038

ESCMID guideline for the diagnosis and management of Candida diseases 2012 : Diagnostic procedures. / Cuenca-Estrella, M.; Verweij, P. E.; Arendrup, M. C.; Arikan-Akdagli, S.; Bille, J.; Donnelly, J. P.; Jensen, H. E.; Lass-Flörl, C.; Richardson, M. D.; Akova, M.; Bassetti, M.; Calandra, T.; Castagnola, E.; Cornely, O. A.; Garbino, J.; Groll, A. H.; Herbrecht, R.; Hope, W. W.; Kullberg, B. J.; Lortholary, O.; Meersseman, W.; Petrikkos, G.; Roilides, E.; Viscoli, C.; Ullmann, A. J.

In: Clinical Microbiology and Infection, Vol. 18, No. SUPPL.7, 12.2012, p. 9-18.

Research output: Contribution to journalArticle

Cuenca-Estrella, M, Verweij, PE, Arendrup, MC, Arikan-Akdagli, S, Bille, J, Donnelly, JP, Jensen, HE, Lass-Flörl, C, Richardson, MD, Akova, M, Bassetti, M, Calandra, T, Castagnola, E, Cornely, OA, Garbino, J, Groll, AH, Herbrecht, R, Hope, WW, Kullberg, BJ, Lortholary, O, Meersseman, W, Petrikkos, G, Roilides, E, Viscoli, C & Ullmann, AJ 2012, 'ESCMID guideline for the diagnosis and management of Candida diseases 2012: Diagnostic procedures', Clinical Microbiology and Infection, vol. 18, no. SUPPL.7, pp. 9-18. https://doi.org/10.1111/1469-0691.12038
Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: Diagnostic procedures. Clinical Microbiology and Infection. 2012 Dec;18(SUPPL.7):9-18. https://doi.org/10.1111/1469-0691.12038
Cuenca-Estrella, M. ; Verweij, P. E. ; Arendrup, M. C. ; Arikan-Akdagli, S. ; Bille, J. ; Donnelly, J. P. ; Jensen, H. E. ; Lass-Flörl, C. ; Richardson, M. D. ; Akova, M. ; Bassetti, M. ; Calandra, T. ; Castagnola, E. ; Cornely, O. A. ; Garbino, J. ; Groll, A. H. ; Herbrecht, R. ; Hope, W. W. ; Kullberg, B. J. ; Lortholary, O. ; Meersseman, W. ; Petrikkos, G. ; Roilides, E. ; Viscoli, C. ; Ullmann, A. J. / ESCMID guideline for the diagnosis and management of Candida diseases 2012 : Diagnostic procedures. In: Clinical Microbiology and Infection. 2012 ; Vol. 18, No. SUPPL.7. pp. 9-18.
@article{dd5a679948ea4d0781387bc911b25e14,
title = "ESCMID guideline for the diagnosis and management of Candida diseases 2012: Diagnostic procedures",
abstract = "As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and to select the most appropriate antifungal drug. A panel of experts of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) undertook a data review and compiled guidelines for the clinical utility and accuracy of different diagnostic tests and procedures for detection of Candida infections. Recommendations about the microbiological investigation and detection of candidaemia, invasive candidiasis, chronic disseminated candidiasis, and oropharyngeal, oesophageal, and vaginal candidiasis were included. In addition, remarks about antifungal susceptibility testing and therapeutic drug monitoring were made.",
keywords = "Biomarkers, Candida, Diagnosis, Guideline, Noncultural",
author = "M. Cuenca-Estrella and Verweij, {P. E.} and Arendrup, {M. C.} and S. Arikan-Akdagli and J. Bille and Donnelly, {J. P.} and Jensen, {H. E.} and C. Lass-Fl{\"o}rl and Richardson, {M. D.} and M. Akova and M. Bassetti and T. Calandra and E. Castagnola and Cornely, {O. A.} and J. Garbino and Groll, {A. H.} and R. Herbrecht and Hope, {W. W.} and Kullberg, {B. J.} and O. Lortholary and W. Meersseman and G. Petrikkos and E. Roilides and C. Viscoli and Ullmann, {A. J.}",
year = "2012",
month = "12",
doi = "10.1111/1469-0691.12038",
language = "English",
volume = "18",
pages = "9--18",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier B.V.",
number = "SUPPL.7",

}

TY - JOUR

T1 - ESCMID guideline for the diagnosis and management of Candida diseases 2012

T2 - Diagnostic procedures

AU - Cuenca-Estrella, M.

AU - Verweij, P. E.

AU - Arendrup, M. C.

AU - Arikan-Akdagli, S.

AU - Bille, J.

AU - Donnelly, J. P.

AU - Jensen, H. E.

AU - Lass-Flörl, C.

AU - Richardson, M. D.

AU - Akova, M.

AU - Bassetti, M.

AU - Calandra, T.

AU - Castagnola, E.

AU - Cornely, O. A.

AU - Garbino, J.

AU - Groll, A. H.

AU - Herbrecht, R.

AU - Hope, W. W.

AU - Kullberg, B. J.

AU - Lortholary, O.

AU - Meersseman, W.

AU - Petrikkos, G.

AU - Roilides, E.

AU - Viscoli, C.

AU - Ullmann, A. J.

PY - 2012/12

Y1 - 2012/12

N2 - As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and to select the most appropriate antifungal drug. A panel of experts of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) undertook a data review and compiled guidelines for the clinical utility and accuracy of different diagnostic tests and procedures for detection of Candida infections. Recommendations about the microbiological investigation and detection of candidaemia, invasive candidiasis, chronic disseminated candidiasis, and oropharyngeal, oesophageal, and vaginal candidiasis were included. In addition, remarks about antifungal susceptibility testing and therapeutic drug monitoring were made.

AB - As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and to select the most appropriate antifungal drug. A panel of experts of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) undertook a data review and compiled guidelines for the clinical utility and accuracy of different diagnostic tests and procedures for detection of Candida infections. Recommendations about the microbiological investigation and detection of candidaemia, invasive candidiasis, chronic disseminated candidiasis, and oropharyngeal, oesophageal, and vaginal candidiasis were included. In addition, remarks about antifungal susceptibility testing and therapeutic drug monitoring were made.

KW - Biomarkers

KW - Candida

KW - Diagnosis

KW - Guideline

KW - Noncultural

UR - http://www.scopus.com/inward/record.url?scp=84867702517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867702517&partnerID=8YFLogxK

U2 - 10.1111/1469-0691.12038

DO - 10.1111/1469-0691.12038

M3 - Article

VL - 18

SP - 9

EP - 18

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - SUPPL.7

ER -